
-
Field of Gold sparkles on opening day of Royal Ascot
-
Alcaraz wins testing Queen's opener, Draper cruises
-
'Second time I've died': Nobel laureate Jelinek denies death reports
-
Oil prices jump, stocks drop as traders track Israel-Iran crisis
-
Swiss insurers estimate glacier damage at $393 mn
-
Premiership club Gloucester sign All Blacks prop Laulala
-
Spain says 'overvoltage' caused huge April blackout
-
Russian strikes kill 10 in 'horrific' attack on Kyiv
-
Record stand puts Bangladesh in command in first Sri Lanka Test
-
Galthie defends second-string France squad for New Zealand tour
-
China's Xi in Kazakhstan to cement 'eternal' Central Asia ties
-
How much damage has Israel inflicted on Iran's nuclear programme?
-
Male victim breaks 'suffocating' silence on Kosovo war rapes
-
Disgraced referee Coote charged by FA over Klopp remarks
-
Queer astronaut documentary takes on new meaning in Trump's US
-
UK startup looks to cut shipping's carbon emissions
-
Roma not aiming for Serie A title 'but you never know', says Gasperini
-
UK automakers cheer US trade deal, as steel tariffs left in limbo
-
Pope Leo XIV to revive papal holidays at summer palace
-
French ex-PM Fillon given suspended sentence over wife's fake job
-
US retail sales slip more than expected after rush to beat tariffs
-
Farrell has no regrets over short France stint with Racing 92
-
Global oil demand to dip in 2030, first drop since Covid: IEA
-
Indonesia volcano spews colossal ash tower, alert level raised
-
Dutch suggest social media ban for under-15s
-
Russian strikes kill 16 in 'horrific' attack on Kyiv
-
Gaza rescuers say Israel army kills more than 50 people near aid site
-
Tehranis caught between fear and resolve as air war intensifies
-
Oil prices rally, stocks slide as traders track Israel-Iran crisis
-
Sweden's 'Queen of Trash' jailed over toxic waste scandal
-
Trump says wants 'real end' to Israel-Iran conflict, not ceasefire
-
Poll finds public turning to AI bots for news updates
-
'Spectacular' Viking burial site discovered in Denmark
-
Why stablecoins are gaining popularity
-
Man Utd CEO Berrada sticking to 2028 Premier League title aim
-
Iraq treads a tightrope to avoid spillover from Israel-Iran conflict
-
Payback time: how Dutch players could power Suriname to the World Cup
-
Oil prices rally, stocks mixed as traders track Israel-Iran crisis
-
Bank of Japan holds rates, will slow bond purchase taper
-
Thai cabinet approves bid to host Bangkok F1 race
-
Oil prices swing with stocks as traders keep tabs on Israel-Iran crisis
-
Amsterdam honours its own Golden Age sculpture master
-
Russian strikes kill 14 in 'horrific' attack on Kyiv
-
Taiwan tests sea drones as China keeps up military pressure
-
Survivors of Bosnia 'rape camps' come forward 30 years on
-
Australian mushroom murder suspect told 'lies upon lies': prosecutor
-
Israel, Iran trade blows as air war rages into fifth day
-
'Farewell, Comrade Boll': China fans hail German table tennis ace
-
G7 urges Middle East de-escalation as Trump makes hasty summit exit
-
With EuroPride, Lisbon courts LGBTQ travellers

Viruses that could save millions of lives
It may seem strange after a pandemic that has killed millions and turned the world upside down, but viruses could save just as many lives.
In a petri dish in a laboratory in the Georgian capital Tbilisi, a battle is going on between antibiotic resistant bacteria and "friendly" viruses.
This small nation in the Caucasus has pioneered research on a groundbreaking way to tackle the looming nightmare of bacteria becoming resistant to the antibiotics on which the world depends.
Long overlooked in the West, bacteriophages or bacteria-eating viruses are now being used on some of the most difficult medical cases, including a Belgian woman who developed a life-threatening infection after being injured in the 2016 Brussels airport bombing.
After two years of unsuccessful antibiotic treatment, bacteriophages sent from Tbilisi cured her infection in three months.
"We use those phages that kill harmful bacteria" to cure patients when antibiotics fail, Mzia Kutateladze of the Eliava Institute of Bacteriophages told AFP.
Even a banal infection can "kill a patient because the pathogen has developed resistance to antibiotics," Kutateladze said.
In such cases, phagotherapy "is one of the best alternatives", she added.
Phages have been known about for a century, but were largely forgotten and dismissed after antibiotics revolutionised medicine in the 1930s.
- Stalin's henchman -
It didn't help that the man who did most to develop them, Georgian scientist Giorgi Eliava, was executed in 1937 on the orders of another Georgian, Lavrentiy Beria, Stalin's most notorious henchman and the head of his secret police.
Eliava had worked in the Pasteur Institute in Paris with French-Canadian microbiologist Felix d'Herelle, one of the two men credited with discovering phages, and persuaded Stalin to invite him to Tbilisi in 1934.
But their collaboration was cut short when Beria had Eliava killed, although his motive still remains a mystery.
With the World Health Organization now declaring antimicrobial resistance a global health crisis, phages are making a comeback, especially as they can target bacteria while leaving human cells intact.
A recent study warned that superbugs could kill as many as 10 million people a year when antimicrobial resistance due to overuse of antibiotics reaches a tipping point. That could come within three decades.
- 'Training' viruses -
While phages-based medicines cannot completely replace antibiotics, researchers say they have major pluses in being cheap, not having side-effects nor damaging organs or gut flora.
"We produce six standard phages that are of wide spectrum and can heal multiple infectious diseases," said Eliava Institute physician Lia Nadareishvili.
In some 10 to 15 percent of patients, however, standard phages don't work and "we have to find ones capable of killing the particular bacterial strain," she added.
Tailored phages to target rare infections can be selected from the institute's massive collection -- the world's richest -- or be found in sewage or polluted water or soil, Kutateladze said.
The institute can even "train" phages so that "they can kill more and more different harmful bacteria."
"It is a cheap and easily accessible therapy," she added.
- Last-resort treatment -
A 34-year-old American mechanical engineer suffering from a chronic bacterial disease for six years told AFP he "already felt improvement" after two weeks at the Tbilisi institute.
"I've tried every possible treatment in the United States," said Andrew, who would only give his first name.
He is one of the hundreds of patients from around the globe who arrive in Georgia every year for last-resort treatment, said Nadareishvili.
With the traditional antimicrobial armoury depleting rapidly, more clinical studies are needed so that phagotherapy can be more widely approved, Kutateladze argued.
In 2019, the United States Food and Drug Administration (FDA) authorised a clinical study on the use of bacteriophages to cure secondary infections in Covid patients.
Beyond medicine, phages are already being used to stop food going off, and they "can be used in agriculture to protect crops and animals from harmful bacteria," Kutateladze said.
The institute has already conducted research on bacteria targeting cotton and rice.
Bacteriophages also have potential to counter biological weapons and combat bioterrorism, with Canadian researchers publishing a 2017 study on using them to counter an anthrax attack on crowded public places.
O.Salim--SF-PST